Status:
COMPLETED
Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)
Lead Sponsor:
AstraZeneca
Conditions:
Osteoarthritis
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this cross-sectional observational real life study is to investigate the patient reported adherence to PPI, when prescribed as prevention of NSAID associated GI Ulcers to pati...
Detailed Description
Cross-sectional, observational Real Life study on NSAIDs treated patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of patient adherence to PPI treatment
Eligibility Criteria
Inclusion
- Confirmed diagnosis (documented in the medical record) of OA, RA or AS
- Prescription of oral NSAID treatment for OA, RA or AS, where low dose is not sufficient
- Prescription of PPI for prevention of NSAID associated GI ulcers, with instruction to take PPI same day as when taking NSAID.
Exclusion
- Participating in any clinical trial involving PPI or NSAID
- Patients prescribed PPI as acute treatment of GI events or symptoms within 8 weeks
- Inability to complete PROs
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT01519375
Start Date
March 1 2012
End Date
May 1 2012
Last Update
May 30 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Kristianstad, Sweden
2
Research Site
Kristinehamn, Sweden
3
Research Site
Limhamn, Sweden
4
Research Site
Partille, Sweden